Search results
Jonathan Lim is a triple-qualified English solicitor, Singapore advocate, and New York lawyer with a focus on complex international disputes.
Jonathan Lim, M.D. currently serves as the Chairman and Chief Executive Officer of Erasca (Nasdaq: ERAS), a company he co-founded, that has a stated mission to erase cancer.
Mr Lim is Co-Chair of the Asia-Pacific Forum for International Arbitration, a Committee Member of the ICC Singapore Regional Projects Sub-Committee, and a member of the SIAC Users Council. He is an Associate Editor of the African Journal of International Arbitration.
Jonathan Lim, M.D., is a physician-turned-venturepreneur who has founded, funded and led multiple biotechnology startups that have brought life-changing therapeutics to patients globally while collectively generating approximately $10 billion in shareholder value.
Jonathan Lim is Founder of Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company that is a portfolio company of City Hill Ventures, LLC, a health care investment firm that he founded in 2010. Jonathan is also a Board Director of Bionomics Ltd (ASX: BNO).
Jonathan is Chairman and CEO of Erasca, which he co-founded in July 2018 with a mission to erase cancer. He is a physician-turned-venturepreneur who, from 2003 to 2018, was a leader and founding investor of four other biotechnology startups that delivered novel therapies for the benefit of patients globally, raised a combined $1 billion in ...
EY Entrepreneur Of The Year – Food and Beverage Solutions. Jonathan Lim founded Oddle with the aim to redefine the F&B industry and the platform has since partnered with some of the region’s most iconic and visible restaurants.
